Canna Law Blog
NOVEMBER 29, 2019
The Food and Drug Administration (“FDA”) had a busy Monday this week. On November 25, the agency issued warning letters to 15 businesses selling hemp-derived CBD (“Hemp-CBD”) products as unapproved drugs. The FDA also released updated consumer guidance on Hemp-CBD. Warning Letters. The recent batch of warning letters appear to turn on the marketing of Hemp-CBD products as unapproved drugs.
Leafly
NOVEMBER 29, 2019
The retail chain with assets including Circle K and Mac’s Milk convenience stores, has been eager to get into legal cannabis retail for years. The post Quebec’s Couche Tard convenience plans to bid on Cannabis NB appeared first on Leafly.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Life Network
NOVEMBER 29, 2019
CBD has become a global phenomenon, whether as a medicine or just a dietary supplement. In reality, a lot of therapeutic effects that people are buying into are really just placebo effects. With that being said, CBD does heal and help with many conditions, especially epilepsy. Many will justly recommend a full-spectrum product to get […]. The post How CBD:THC Blends Work: Half Baked – Exploring the Biases of NAM appeared first on Cannabis News | Lifestyle Tips | Expert Opinions | Sto
Leafly
NOVEMBER 29, 2019
Hoping to compete with an entrenched legacy market composed largely of delivery services, the SQDC wants to introduce delivery within 24 hours. The post Quebec looks into same-day delivery to battle illicit market appeared first on Leafly.
Speaker: Jonathan Bench, International Cannabis and Securities Business Attorney at Harris Bricken
The U.S. cannabis industry is still in its infancy, even though states began engaging with legalization in one form or another in the late 1990s. Today, many opportunities exist for individuals and businesses that want to engage in the industry. Some want to directly own licensed businesses, while others prefer to keep the industry at an arm’s length and merely profit from it.
Cannabis Law Report
NOVEMBER 29, 2019
Tetrahydrocannabinol (THC) is the element in cannabis that gets a person high. But, this is just one of the more than 400 compounds that are found in cannabis. But, this compound has other benefits and effects other than being the one that makes a user high. What is Tetrahydrocannabinol? THC is the psychoactive compound in cannabis. That’s why it is responsible for the high feeling a person gets after using marijuana.
Medical Cannabis Brief brings together the best content for patients and advocates from the widest variety of industry thought leaders.
Cannabis Law Report
NOVEMBER 29, 2019
Here’s the press release.
Cannabis Law Report
NOVEMBER 29, 2019
Grizzle report… A senior member of the Singapore government has voiced concern about the increasingly liberal approach to cannabis that various countries have adopted. Thailand legalized medical cannabis use at the end of 2018 and it has already started supplying patients with products from a government-owned facility near Bangkok. The Thai capital is hosting the 13th Asean Ministerial Meeting on Transnational Crime, which brings together representatives of the 10 members that make up
Cannabis Law Report
NOVEMBER 29, 2019
Euractiv report… Germany’s regulatory approach to medical cannabis is good practice and should be replicated across Europe, according to newly-born European Medicinal Cannabis Association (EUMCA). The recently established lobby group is taking its first steps in the Brussels bubble, advocating for an EU-wide regulatory framework on medical marijuana.
Cannabis Law Report
NOVEMBER 29, 2019
LONDON — Up to five companies active in the cannabis industry could go public in 2020 in Europe, a continent whose stock markets have largely missed out on the North-American “pot stocks” frenzy, a leading industry analyst said on Thursday. …/… “I think there will be 4 or 5 companies quoted in twelve months time”, Nikolaas Faes, an analysts for Bryan Garnier told Reuters on the sidelines of a cannabis industry conference.
Cannabis Law Report
NOVEMBER 29, 2019
The cannabis plant contains more than 500 identified chemical constituents. More than 100 of them are cannabinoids. Medical marijuana uses the cannabis plant or its basic chemicals to treat a whole bunch of different diseases and conditions. Delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) are the main chemicals used in medicine. When cannabinoids enter the human body, they start interacting with the endocannabinoid system which is the network of cell receptors throughout the brain and b
Expert insights. Personalized for you.
145 
Let's personalize your content